Jacobson, B.F.; Louw, S.; Mer, M.; Haas, S.; Büller, H.R.; Abdul-Carim, A.T.; Adler, D.; Beaton, A.; de Jong, P.R., van der Jagt, D.; Levy, B.; Pearl, J.; Schapkaitz, E.; Wessels, P. Venous Thromboembolism-prophylactic and therapeutic practice guidelineS Afr Med J2009996
Sanchez-Antequera, Y.; Cengizeroglu, A.; Kopera A.;, Mykhaylyk, O.; Johnston, J,.; A novel non-viral and viral technology for ex-vivo gene therapy: Magselectofection1411 Or 84ESGCT, DGGT, GSZ, AND ISCT 20092009
Trueck, C.; Mykhaylyk, O.; Zimmermann, K.; Wenzel, D.; Becher, U.; Hofmann, A.; Gleich, B.; Fleischmann, B.; Plank, C, Pfeifer, A.Targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles1386ESGCT, DGGT, GSZ, AND ISCT 20092009
Schillinger, U.; Rutz, M.; Fischer C.; Jahnke A.; Walsch F.; Ferizi, M.; Benda, V.; Schwarz B.; Kempf T.; Hirschberger J.; Köstlin, R.; Brill T., Gänsbacher B.; Plank, C.Adjuvant immunostimulatory therapy by magnetofection prolonged relapse-free survival for fibrosarcoma bearing cats1384ESGCT, DGGT, GSZ, and ISCT 20092009
Haas, SNew anticoagulants - towards the development of an "ideal" anticoagulant.Vasa200938113-29
Plank, C;Rosenecker, JMagnetofection: the use of magnetic nanoparticles for nucleic acid delivery.CSH Protoc200920096pdb.prot5230
Mykhaylyk, O;Steingotter, A;Perea, H;Aigner, J;Botnar, R;Plank, CNucleic acid delivery to magnetically-labeled cells in a 2D array and at the luminal surface of cell culture tube and their detection by MRI.J Biomed Nanotechnol200956692-706
Obermeier, A;Matl, FD;Friess, W;Stemberger, AGrowth inhibition of Staphylococcus aureus induced by low-frequency electric and electromagnetic fields.Bioelectromagnetics2009304270-9
Haas, S;Bauersachs, R[Prevention of deep vein thrombosis in surgical and non-surgical patients]Hamostaseologie200929191-5
Haas, SRivaroxaban -- an oral, direct Factor Xa inhibitor: lessons from a broad clinical study programme.Eur J Haematol2009825339-49